|
Exanthema
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
18F-FDG PET/CT-Guided Diagnosis and Evaluation of Treatment Response to Cyclosporine A in Maldistributed Subcutaneous Panniculitis-like T-Cell Lymphoma Without Typical Skin Rash.
|
31833924 |
2020 |
|
Facial paralysis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The Monocle Sign in FDG-PET: A Sign of Contralateral Facial Nerve Palsy.
|
31693602 |
2020 |
|
Graft-vs-Host Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
18F-FDG PET/CT in Graft Versus Host Disease-Associated Polymyositis.
|
31693622 |
2020 |
|
Q Fever
|
0.010 |
Biomarker
|
disease |
BEFREE |
The first point is that Q fever diagnosis has been reviewed in the light of the new diagnosis tools, including molecular biology, transthoracic echocardiography, and 18F-FDG-PET/CT-scan imaging.
|
31782315 |
2020 |
|
Sarcoidosis, Pulmonary
|
0.010 |
Biomarker
|
disease |
BEFREE |
18F-FDG PET/CT in Pulmonary Sarcoidosis:Quantifying Inflammation by the TLG index.
|
31626563 |
2020 |
|
Gastrointestinal Carcinoid Tumor
|
0.010 |
Biomarker
|
disease |
BEFREE |
PET/CT is often ordered as well to measure the extent of disease and for follow-up, but its usefulness is in question as some GCTs lack FDG avidity.
|
31410505 |
2020 |
|
Hemichorea
|
0.010 |
Biomarker
|
disease |
BEFREE |
F-FDG PET/CT showed marked hypometabolism in the basal ganglia contralateral to the side with hemichorea.
|
31714279 |
2020 |
|
Disseminated nocardiosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
18F-FDG Imaging of a Case of Disseminated Nocardiosis.
|
31789913 |
2020 |
|
Bell Palsy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The Monocle Sign in FDG-PET: A Sign of Contralateral Facial Nerve Palsy.
|
31693602 |
2020 |
|
Pilomatrix carcinoma of skin
|
0.010 |
Biomarker
|
disease |
BEFREE |
18F-FDG PET/CT Findings in Metastatic Pilomatrix Carcinoma.
|
31833930 |
2020 |
|
Sarcopenia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Characterization of psoas muscles as a surrogate marker for sarcopenia on baseline <sup>18</sup>F-FDG PET/CT imaging is relatively easily obtained and may offer additional prognostic value in patients with EAC.
|
31823231 |
2020 |
|
Metastatic Prostate Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The Great Mimicker-Tuberculosis Involving Prostate and Vertebrae Posing as Metastatic Prostate Carcinoma on FDG PET/CT.
|
31652162 |
2020 |
|
Familial multiple trichoepitheliomata
|
0.010 |
Biomarker
|
disease |
BEFREE |
Characterization of psoas muscles as a surrogate marker for sarcopenia on baseline <sup>18</sup>F-FDG PET/CT imaging is relatively easily obtained and may offer additional prognostic value in patients with EAC.
|
31823231 |
2020 |
|
Adenocarcinoma of the gastroesophageal junction
|
0.010 |
Biomarker
|
disease |
BEFREE |
The aim of this study was to evaluate F-FDG PET/CT in assessing metabolic response in patients with AEG.
|
31714278 |
2020 |
|
Aggressive reaction
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Data from <sup>18</sup>F-FDG PET/CT studies showed that standardised uptake value (SUV) is significantly associated with the aggressiveness, treatment response and prognosis of this disease.
|
31392480 |
2020 |
|
Columnar Cell Change of the Breast
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
18F-FDG PET/CT-based metabolic volumetric parameters might be predicators for survival in ovarian CCC patients.
|
31796665 |
2020 |
|
Round atelectasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
False-Positive 18F-FDG and 18F-Fluorothymidine Uptake in a Patient With Round Atelectasis.
|
31833928 |
2020 |
|
Ovarian clear cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The role of 18F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma.
|
31796665 |
2020 |
|
Breast implant-associated anaplastic large cell lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
FDG PET/CT and Ultrasound Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
|
31693606 |
2020 |
|
ACTH Syndrome, Ectopic
|
0.010 |
Biomarker
|
disease |
BEFREE |
In Cushing disease patients, the pituitary maximum standardized uptake value F-FDG PET/CT (n=11) did not show significant differences compared with that in ectopic ACTH syndrome (EAS) patients (n=20).
|
30973841 |
2019 |
|
Anemia, Hemolytic
|
0.010 |
Biomarker
|
disease |
BEFREE |
PET/CT revealed splenomegaly with focally intense uptake of F-FDG and diffusely increased bone marrow uptake, which was considered to be secondary to hemolytic anemia.Splenectomy was performed.
|
30888998 |
2019 |
|
Anemia, Sickle Cell
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Fluorine-18-FDG PET/CT completes the whole-body assessment with an integrated multimodal approach with high spatial resolution that evaluates the metabolic activity and the standardized uptake value (SUV) in SCD patients.
|
30843001 |
2019 |
|
Fabry Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
We investigated the relationship between T1 mapping and 18F-FDG uptake by hybrid PET-MR cardiac imaging in AFD female patients.
|
30879055 |
2019 |
|
Bipolar Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Finally, we demonstrated that the FDG uptake reduction in fusiform gyrus is associated with the presence of past psychotic symptoms in BD, ultimately leading towards the idea that the fusiform gyrus might be considered a putative biomarker of psychosis.
|
30506616 |
2019 |
|
Bone Marrow Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
We review the cases of three patients who presented with myelopathy and underwent F-FDG DTPI as part of the evaluation for enhancing spinal cord lesions of unknown etiology for 2 years at a university-based cancer hospital.
|
31634300 |
2019 |